Mood Disorders and the Outcome of Suicidal Thoughts and Attempts

Critical Care Clinics

Volumn 24, Issue 4, 2008, Pages 857-874

  Dubovsky, Steven L ^a,b   Dubovsky, Amelia N ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; LITHIUM; LORAZEPAM; MIDAZOLAM; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGITATION; ALCOHOLISM; CLINICAL TRIAL; COGNITIVE THERAPY; FAMILY HISTORY; GENERALIZED ANXIETY DISORDER; HOPELESSNESS; HUMAN; INTENSIVE CARE; MAJOR DEPRESSION; MOOD DISORDER; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL PHOBIA; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT;

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; ANTIDEPRESSIVE AGENTS; CHILD; CRITICAL CARE; ELECTROSHOCK; FEMALE; HUMANS; MALE; PREVALENCE; RISK FACTORS; SUICIDE; SUICIDE, ATTEMPTED; UNITED STATES; YOUNG ADULT;

EID: 53249137869     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.05.002     Document Type: Review

References (77)

1. Claassen C.A., Trivedi M.H., Rush A.J., et al. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disord 97 (2007) 77-84
2. Bossuyt N., and Van Casteren V. Epidemiology of suicide and suicide attempts in Belgium: results from the sentinel network of general practitioners. Int J Public Health 52 (2007) 153-157
3. Reseland S., Le Nourv J., Aldred G., et al. National suicide rates 1961-2003: further analysis of Nordic data for suicide, autopsies, and ill-defined death rates. Psychother Psychosom 77 (2008) 78-82
4. Feldman M.D., Franks P., Duberstein P.R., et al. Let's not talk about it: suicide inquiry in primary care. Ann Fam Med 5 (2007) 412-418
5. Mattisson C., Bogren M., Horstmann V., et al. The long-term course of depressive disorders in the Lundby study. Psychol Med 37 (2007) 883-891
6. Lonnqvist J.K., Henriksson M.M., Isometsa E.T., et al. Mental disorders and suicide prevention. Psychiatry Clin Neurosci 49 Suppl 1 (1995) S111-S116
7. Szanto K., Kalmar S., Hendin H., et al. A suicide prevention program in a region with a very high suicide rate. Arch Gen Psychiatry 64 (2007) 914-920
8. Shain B.N. Suicide and suicide attempts in adolescents. Pediatrics 120 (2007) 669-676
9. Foley P.L., Goldston D.B., Costello E.J., et al. Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. Arch Gen Psychiatry 63 (2006) 1017-1024
10. Gaynes B.N., Rush A.J., Trivedi M.H., et al. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Ann Fam Med 5 (2007) 126-134
11. Goodwin F.K., and Jamison K.R. Manic depressive illness (1991), Oxford University Press, New York
12. Romero S., Colom F.I., Losif A.M., et al. Relevance of family history of suicide in the long-term outcome of bipolar disorders. J Clin Psychiatry 68 (2007) 1517-1521
13. Altamuraa A.C., Bobob W.V., and Meltzer H.Y. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment. Int Clin Psychopharmacol 22 (2007) 249-267
14. Gonzalez-Pinto A., Aldama A., Gonzalez C., et al. Predictors of suicide in first-episode affective and nonaffective psychotic inpatients: five-year follow-up of patients from a catchment area in Vitoria. Spain. J Clin Psychiatry 68 (2007) 242-247
15. Meltzer H.Y., Alphs L., Green A., et al. Clozapine treatment for suicidality in schizophrenia. International Suicide Prevention Trial. Arch Gen Psychiatry 60 (2003) 82-91
16. Darke S., Ross J., Williamson A., et al. Patterns and correlates of attempted suicide by heroin users over a 3-year period: findings from the Australian treatment outcome study. Drug Alcohol Depend 87 (2007) 146-152
17. Cherpitel C.J., Bond J., Ye Y., et al. A cross-national meta-analysis of alcohol and injury: data from the Emergency Room Collaborative Alcohol Analysis Project (ERCAAP). Addiction 98 (2003) 1277-1286
18. Kelly C., and Galloway R. Deliberate self-poisoning presenting at Craigavon area hospital: 1976 and 1986. Ulster Med J 61 (1992) 12-18
19. Conner K.R., Beautrais A.L., and Conwell Y. Moderators of the relationship between alcohol dependence and suicide and medically serious suicide attempts: analyses of Canterbury Suicide Project data. Alcohol Clin Exp Res 27 (2003) 1156-1171
20. Preuss U.W., Schuckit M.A., Smith T.L., et al. A comparison of alcohol-induced and independent depression in alcoholics with histories of suicide attempts. J Stud Alcohol 63 (2002) 498-502
21. Swahn M.H., and Bossarte R.M. Gender, early alcohol use, and suicide ideation and attempts: findings from the 2005 youth risk behavior survey. J Adolesc Health 41 (2007) 175-181
22. Blumenthal R. Suicidal gunshot wounds to the head: a retrospective review of 406 cases. Am J Forensic Med Pathol 28 (2007) 288-291
23. Makhija N., and Sher L. Childhood abuse, adult alcohol use disorders and suicidal behaviour. QJM 100 (2007) 305-309
24. Herba C.M., Ferdinand R.F., Van der Ende J., et al. Long-term associations of childhood suicide ideation. J Am Acad Child Adolesc Psychiatry 46 (2007) 1473-1481
25. Spirito A., and Esposito-Smythers C. Attempted and completed suicide in adolescence. Annu Rev Clin Psychol 2 (2006) 237-266
26. O'Carroll P.W., Potter L.B., and Mercy J.A. Programs for the prevention of suicide among adolescents and young adults. MMWR Recomm Rep 43 RR-6 (1994) 1-7
27. Prevention CfDCa: CDC Wonder [database]: mortality query. Available at:. http://wonder.cdc.gov.2006 Accessed April 25, 2008
28. Husain S.A. Current perspective on the role of psychological factors in adolescent suicide. Psychiatr Ann 20 (1990) 122-127
29. Centers for Disease Control and Prevention. Youth risk behavior surveillance-United States, 2003. MMWR Surveill Summ 53 2 (2004) 1-96. Available at: www.cdc.gov/mmwr/PDF/SS/SS5302.pdf Accessed April 25, 2008
30. Centers for Disease Control and Prevention. Suicide prevention scientific information: risk and protective factors-United States 1999. Available at:. http://www.cdc.gov/ncipc/dvp/suicide/Suicide-risk-p-factors.htm Accessed April 21, 2008
31. Centers for Disease Control. Prevention CfDCa: youth risk behavior surveillance-United States, 2003. MMWR Morb Mortal Wkly Rep 53 (2004) 536
32. Rice F., Lifford K.J., Thomas H.V., et al. Mental health and functional outcomes of maternal and adolescent reports of adolescent depressive symptoms. J Am Acad Child Adolesc Psychiatry 46 (2007) 1162-1170
33. Administration USFaD: PDA public health advisory: suicidality in children and adolescents being treated with antidepressant medications. Available at:. 2006 www.fda.gov/cder/drug/antidepressants/SSRIPHA200410.htm Accessed April 25, 2008
34. Olfson M., Marcus S.C., and Druss B.G. Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry 65 (2008) 94-101
35. Hammad T.A., Langhren T., and Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63 (2006) 332-339
36. Emslie G.J., Waslick B., Weller E.B., et al. Antidepressant management in the context of suicidal ideation. J Am Acad Child Adolesc Psychiatry 46 (2007) 1222-1225
37. Olfson M., Shaffer D., Marcus S.C., et al. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60 (2003) 978-982
38. Libby A.M., Brent D.A., Morrato E.H., et al. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 164 (2007) 884-891
39. Valuck R.J., Libby A.M., Orton H.P., et al. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 164 (2007) 1198-1205
40. Morrato E.H., Libby A.M., Orton H.P., et al. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 165 (2008) 42-50
41. Banki C.M. Prophylactic potential of selective reuptake inhibitors in suicidal patients. Int Clin Psychopharmacol 9 Suppl 4 (1995) 61-65
42. Bellivier F., Szoke A., Henry C., et al. Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol Psychiatry 48 (2000) 319-322
43. Linnoila M., and Virkkunen M. Biologic correlates of suicidal risk and aggressive behavioral traits. J Clin Psychopharmacol 12 (1992) 19S-20S
44. Dubovsky S.L., and Thomas M. Beyond specificity: effects of serotonin and serotonergic treatments on psychobiological dysfunction. J Psychosom Res 39 4 (1995) 429-444
45. Perlis R.H., Purcell S., Fava M., et al. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry 64 (2007) 689-697
46. Vaiva G., Ducrocq F., Meyer P., et al. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ 332 (2006) 1241-1246
47. Nordstrom P., Samuelsson M., and Asberg M. Survival analysis of suicide risk after attempted suicide. Acta Psychiatr Scand 91 5 (1995) 336-340
48. Hjelmeland H. Verbally expressed intentions of parasuicide: II. Prediction of fatal and nonfatal repetition. Crisis 17 1 (1996) 10-14
49. Bruce M.L., Ten Have T.R., Reynolds C.F., et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 291 (2004) 1081-1091
50. Agerbo E. High income, employment, postgraduate education, and marriage: a suicidal cocktail among psychiatric patients. Arch Gen Psychiatry 64 (2007) 1377-1384
51. Beck A.T., and Weishaar M.E. Suicide risk assessment and prediction. Crisis 11 2 (1990) 22-30
52. Hughes S.L., and Neimeyer R.A. Cognitive predictors of suicide risk among hospitalized psychiatric patients: a prospective study. Special issue: prevention and postvention of suicide. Death Stud 17 2 (1993) 103-124
53. Olshen E., McVeigh K.H., Wunsch-Hitzig R.A., et al. Dating violence, sexual assault, and suicide attempts among urban teenagers. Arch Pediatr Adolesc Med 161 (2007) 539-545
54. Davies S., Clarke M., Hollin C., et al. Long-term outcomes after discharge from medium secure care: a cause for concern. Br J Psychiatry 191 (2007) 70-74
55. Salari S. Patterns of intimate partner homicide suicide in later life: strategies for prevention. Clin Interv Aging 2 (2007) 441-452
56. Whitlock J., and Knox K.L. The relationship between self-injurious behavior and suicide in a young adult population. Arch Pediatr Adolesc Med 161 (2007) 634-640
57. Khan A., and Schwartz K. Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the PDA summary basis of approval reports. Ann Clin Psychiatry 19 (2007) 31-36
58. Cantor C.H., and McDermott P.M. Suicide litigation: from legal to clinical wisdom. Aust N Z J Psychiatry 28 3 (1994) 431-437
59. Goldstein R.B., Black D.W., Nasrallah A., et al. The prediction of suicide: sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry 48 5 (1991) 418-422
60. Edwards R.R., Magyar-Russell G., Thombs B., et al. Acute pain at discharge from hospitalization is a prospective predictor of long-term suicidal ideation after burn injury. Arch Phys Med Rehabil 88 12 Suppl 2 (2007) S36-S42
61. Rudd M.D., Mandmsiak M., and Joiner Jr. T.E. The case against no-suicide contracts: the commitment to treatment statement as a practice alternative. J Clin Psychol 62 (2006) 243-251
62. de Anda D., and Smith M.A. Differences among adolescent, young adult, and adult callers of suicide help lines. Soc Work 38 (1993) 421-428
63. Bridge T.P., Potkin S.G., Zung W.W., et al. Suicide prevention centers: ecological study of effectiveness. J Nerv Ment Dis 164 (1977) 18-24
64. Kutcher S.P., and Szumilas M. Youth suicide prevention. CMAJ 178 (2008) 282-285
65. Prevention CfDCa: Suicide prevention scientific information: risk and protective factors United States 1999. Available at:. http://www.cdc.gov/ncipc/dvp/suicide/Suicide-risk-p-factors.htm Accessed April 25, 2008
66. Dubovsky S.L., and Weissberg M.P. Clinical psychiatry in primary care. 3rd edition (1986), Williams and Wilkins, Baltimore (MD)
67. Cosgrave E.M., Robinson J., Godfrey K.A., et al. Outcome of suicidal ideation and behavior in a young, help-seeking population over a 2-year period. Crisis 28 (2007) 4-10
68. Clarkin J.F., Levy K.N., Lenzenweger M.F., et al. Evaluating three treatments For borderline personality disorder: a multiwave study. Am J Psychiatry 164 (2007) 922-928
69. Linehan M.M., Comtois K.A., Murray A.M., et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 63 7 (2006) 757-766
70. Stanley B., Brodsky B., Nelson J.D., et al. Brief dialectical behavior therapy (DBT-B) for suicidal behavior and non-suicidal self injury. Arch Suicide Res 11 4 (2007) 337-341
71. Centers for Disease Control and Prevention. CDC Wonder [database]: mortality query. Available at:. http://wonder.cdc.gov Accessed October 9, 2006
72. US Food and Drug Administration. FDA public health advisory: suicidality in children and adolescents being treated with antidepressant medications. Available at:. www.fda.gov/cder/drug/antidepressants/SSRIPHA200410.htm Accessed October 9, 2006
73. Muller-Oerlinghausen B., Berghofer A., and Ahrens B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can J Psychiatry 48 (2003) 433-439
74. Smith D., and Wesson P.R. Berizodiazepines and other sedative-hypnotics. In: Galanter M., and Kleber H.P. (Eds). American psychiatric press textbook of substance abuse treatment. 2nd edition (1999), American Psychiatric Press, Washington, DC 239-250
75. Lukens T.W., Wolf S.J., Edlow J.A., et al. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department. Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Ann Emerg Med 47 (2006) 79-99
76. Schneider L.S., Tariot P.N., Dagerman K.S., et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's. N Engl J Med. 355 (2006) 1525-1538
77. Dubovsky S.L. Using electroconvulsive therapy for patients with neurological disease. Hosp Community Psychiatry 37 (1986) 819-825